MedTrace Logo

Diabetes-specific Formula (DSF) in Individuals With Type 2 Diabetes

NCT05802927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2023-10-27

No results posted yet for this study

Summary

A randomized, controlled, crossover design with three treatments to determine the effects of diabetes-specific formula on glycemic control in individuals with type 2 diabetes.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

DSF

Diabetes-specific formula

OTHER

Breakfast 1

Noodle Soup

OTHER

Breakfast 2

Glutinous rice

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Agnes Siew Ling Tey, PhD · Abbott Nutrition R&D

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-05
Primary Completion
2023-10-26
Completion
2023-10-26

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05802927 on ClinicalTrials.gov